Loading...
Please wait, while we are loading the content...
Similar Documents
Genetic Testing for Alzheimer’s Disease and its Impact on Insurance Purchasing Behavior
| Content Provider | PubMed Central |
|---|---|
| Author | Zick, Cathleen D. Mathews, Charles Roberts, J. Scott Robert, Cook-deegan Pokorski, Robert J. Green, Robert C. |
| Abstract | New genetic tests for adult-onset diseases raise concerns about possible adverse selection in insurance markets. To test for this behavior, 148 cognitively normal individuals participating in a randomized clinical trial of genetic testing for Alzheimer’s disease (AD) were tracked for one year after risk assessment and APOE genotype disclosure. Although no significant differences were found in health, life, or disability insurance purchases, those who tested positive were 5.76 times more likely to have altered their long-term care insurance than individuals who did not receive APOE genotype disclosure. If genetic testing for AD risk assessment becomes common, it could trigger adverse selection in the long-term care insurance market. |
| Related Links | http://dx.doi.org/10.1377/hlthaff.24.2.483 |
| Ending Page | 490 |
| Page Count | 8 |
| Starting Page | 483 |
| File Format | |
| ISSN | 02782715 |
| e-ISSN | 15445208 |
| Journal | Health affairs (Project Hope) |
| Issue Number | 2 |
| Volume Number | 24 |
| Language | English |
| Publisher Date | 2005-03-01 |
| Access Restriction | Open |
| Subject Keyword | Medicine(all) Research in Higher Education |
| Content Type | Text |
| Resource Type | Article |
| Subject | Health Policy |
